ScinoPharm Taiwan, Ltd. (TPE: 1789)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
22.25
-0.10 (-0.45%)
Jan 20, 2025, 1:30 PM CST

ScinoPharm Taiwan Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
3,9763,9424,2954,0814,0553,305
Upgrade
Short-Term Investments
-----172.22
Upgrade
Cash & Short-Term Investments
3,9763,9424,2954,0814,0553,477
Upgrade
Cash Growth
-0.47%-8.22%5.24%0.64%16.62%-20.65%
Upgrade
Accounts Receivable
445.57788.22635.26360.25386.51590.34
Upgrade
Other Receivables
29.3525.2318.2832.886.4380.12
Upgrade
Receivables
474.91813.45653.55393.04472.93670.45
Upgrade
Inventory
1,8771,5121,1891,3451,2461,124
Upgrade
Prepaid Expenses
157.93105.79132.2496.85108.08131.68
Upgrade
Other Current Assets
1.978.351.1350.7134.312.92
Upgrade
Total Current Assets
6,4876,3816,3205,9675,9165,407
Upgrade
Property, Plant & Equipment
4,3914,3994,4984,6484,8415,107
Upgrade
Long-Term Investments
74.5669.97112.62185.8308.12415.21
Upgrade
Other Intangible Assets
22.6119.159.958.798.914.07
Upgrade
Long-Term Deferred Tax Assets
637.52640.93637.44614.98602.98606.12
Upgrade
Other Long-Term Assets
171.62211.48332.96267.07170125.63
Upgrade
Total Assets
11,78411,72211,91111,69111,84711,675
Upgrade
Accounts Payable
128.57102.46126.570.86160.84102.37
Upgrade
Accrued Expenses
129.89139.78139.6124.62125.97104.46
Upgrade
Short-Term Debt
35.732.1477.6-9.4989.77
Upgrade
Current Portion of Long-Term Debt
-----144.23
Upgrade
Current Portion of Leases
18.2917.5617.8916.1716.516.01
Upgrade
Current Income Taxes Payable
11.862.699.6471.1767.970
Upgrade
Current Unearned Revenue
157.76110.9767.7570.5766.8555.99
Upgrade
Other Current Liabilities
212.03263.96274.12202.93239.02228.92
Upgrade
Total Current Liabilities
694.04729.45803.09556.31686.65741.75
Upgrade
Long-Term Leases
622.14570.23581.18540.27550.18590.02
Upgrade
Long-Term Deferred Tax Liabilities
0.41.66-0.35-0.58
Upgrade
Other Long-Term Liabilities
4.341.32.363.651.30.09
Upgrade
Total Liabilities
1,3441,3571,4611,1801,3171,415
Upgrade
Common Stock
7,9077,9077,9077,9077,9077,907
Upgrade
Additional Paid-In Capital
1,2951,2951,2951,2951,2951,295
Upgrade
Retained Earnings
1,3531,3481,3461,3701,3601,126
Upgrade
Comprehensive Income & Other
-115.17-185.86-98.18-61.13-33.04-67.83
Upgrade
Shareholders' Equity
10,44010,36410,45010,51110,52910,260
Upgrade
Total Liabilities & Equity
11,78411,72211,91111,69111,84711,675
Upgrade
Total Debt
676.13619.92676.67556.43576.18840.03
Upgrade
Net Cash (Debt)
3,3003,3223,6183,5243,4792,637
Upgrade
Net Cash Growth
-1.38%-8.19%2.65%1.31%31.91%-11.21%
Upgrade
Net Cash Per Share
4.164.194.564.454.393.33
Upgrade
Filing Date Shares Outstanding
790.74790.74790.74790.74790.74790.74
Upgrade
Total Common Shares Outstanding
790.74790.74790.74790.74790.74790.74
Upgrade
Working Capital
5,7935,6515,5175,4105,2294,665
Upgrade
Book Value Per Share
13.2013.1113.2213.2913.3212.98
Upgrade
Tangible Book Value
10,41710,34510,44010,50210,52110,246
Upgrade
Tangible Book Value Per Share
13.1713.0813.2013.2813.3012.96
Upgrade
Buildings
4,3104,2494,0953,5463,5183,496
Upgrade
Machinery
6,6226,4326,2495,6415,5985,579
Upgrade
Construction In Progress
97.3477.72155.621,1191,0521,014
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.